US will manufacture monkeypox vaccine in bid to expedite delivery

URLhttps://thehill.com/policy/healthcare/3607206-u-s-
SourceThe Hill
Date Published08/18/2022
Author NameNATHANIEL WEIXEL
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Grand River Aseptic Manufacturing (GRAM)
Parent companyBavarian Nordic
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Reshoring
Year reshoring announced:2022
Year reshoring implemented or to be implemented:2023
Country(ies) from which reshored:Denmark
City reshored to:Grand River
State(s) reshored to:MI
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredmonkeypox vaccine
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Higher productivity, Image/brand, Proximity to customers/market
Find Reshoring Articles